Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nevis Brands Inc C.NEVI

Alternate Symbol(s):  NEVIF

Nevis Brands Inc., formerly Pascal Biosciences Inc., provides cannabis brands throughout the United States. The Company provides products in Washington, Oregon, California, Ohio, Arizona and Colorado through partners and licensees. Its products include the flagship brand Major, which is a cannabis beverage. Major is a high-dose tetrahydrocannabinol (THC) beverage that delivers a consistent cannabis experience with no cannabis taste or smell. Major offers various flavors, such as volcanic orange mango, sunset pink lemonade, Pacific Coast blue raspberry, dreamin' of passion, and sacred grape. It also offers Major Minis, which is a smaller 2 ounce (oz) shot. Major Minis come in three flavors, such as blueberry, fruit punch, and blackberry lemonade. The Company has introduced Major Mojo-Rita and Sugar-Free Ginger-ade in Washington and Major Sugar-Free Lemonade and Apple Peach in Missouri.


CSE:NEVI - Post by User

Bullboard Posts
Comment by Mickey7on Mar 05, 2018 9:02am
80 Views
Post# 27660204

RE:RE:weed pharma comparison by marketcap

RE:RE:weed pharma comparison by marketcapInmed has a topical application using THC I believe ( correct me if i'm wrong). But what these findings show is to help identify and kill tumour cells. We are very early but, this is how i think Pascal seperates itself from the rest...while every company is in the search to identfity the checkpoint inhibitors, pascal was the first to do it. Now that I think about it,  best case scenario is they either patent the findings or get bought out.

There is a growing body of research demonstrating the effectiveness of cannabinoids in the treatment of cancer symptoms, including nausea, appetite enhancement and pain management. However, Pascal is the first to identify a mechanism in which cannabinoids may provide a direct benefit in immunotherapy.
Bullboard Posts